Pleural fluid supernatant cfDNA should be routinely preserved and can already be used selectively for molecular profiling in NSCLC, while broader implementation requires prospective clinical validation.
No takes yet. Share an insight, caveat, or question.
José Manuel Porcel (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: